Extendicare Inc. (TSE:EXE – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$10.75 and traded as high as C$13.04. Extendicare shares last traded at C$12.99, with a volume of 193,086 shares traded.
Wall Street Analyst Weigh In
EXE has been the subject of a number of analyst reports. BMO Capital Markets increased their price target on Extendicare from C$11.00 to C$13.50 in a report on Monday, March 3rd. Cormark upgraded Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th. Finally, TD Securities raised their price target on shares of Extendicare from C$10.50 to C$13.00 and gave the stock a “hold” rating in a research report on Monday, March 3rd.
Check Out Our Latest Stock Analysis on Extendicare
Extendicare Stock Down 0.3 %
Extendicare Dividend Announcement
The company also recently announced a monthly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 17th were given a $0.04 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.48 annualized dividend and a dividend yield of 3.71%. Extendicare’s payout ratio is 61.20%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- How to Find Undervalued Stocks
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- Growth Stocks: What They Are, What They Are Not
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.